Press Release: VEM sells ratiopharm Group to Teva – ratiopharm to become the hub for Teva’s European growth strategy

The ratiopharm Group gets a new owner. Subsequent to an extensive bidding process, the Israel-based company Teva Pharmaceutical Industries Ltd. is going to acquire the Ulm based company from Merckle Group’s VEM asset management.

About ratiopharm

ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines and sell them at low prices. By doing so, we contribute to cost containment in the healthcare sector.

Job Center

We are looking for you - Apply for a job at a top brand now!